Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and Effects on Quality of Life. RSD 2025, 14 (5), e4914548812. https://doi.org/10.33448/rsd-v14i5.48812.